| 查看: 1441 | 回复: 11 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 wlg001 的 19 个金币 ,回帖就立即获得 1 个金币,每人有 1 次机会 | |||
[交流]
欢迎投稿Frontiers in Bioengineering and Biotechnology影响因子6.064
|
|||
|
SCI期刊:Frontiers in Bioengineering and Biotechnology, 影响因子6.064,审稿速度快!! 欢迎投稿专刊 Special Issue " nanomaterials for drug delivery " ! (链接https://www.frontiersin.org/rese ... s-for-drug-delivery) 论文主题包含下面,但不仅限于下面: In modern society, human beings suffer from various diseases. To treat diseases, numerous medication types have been developed. However, many small molecule drugs have low absorption and substantially adverse effects. Thus, it is necessary to solve these problems through the nanomaterials used as drug carriers. To improve the therapeutic effect of small molecule drugs, it is important to enhance the efficiency of targeted and controlled drug delivery. Various kinds of nanomaterials have been developed recently to investigate their characteristics and applications in drug delivery. The efficiency of drug delivery has been significantly improved by the wide use of lipid-based nanomaterials, inorganic or organic nanoparticle-based nanomaterials, polymer-based nanomaterials, hydrogel-based nanomaterials and biomimetic nanomaterials. During the investigation, the physical, chemical and catalytic property has an important effect on the efficiency of drug delivery. Therefore, it is important to reveal these factors on the efficiency of drug delivery. This Research Topic focuses on the structure, function and mechanisms of nanomaterials in the application of drug delivery, and it is devoted to the dissemination of high-quality original research articles or comprehensive reviews on cutting-edge developments in this interdisciplinary field. All types of manuscripts, such as Original Research, Review, Mini-Review, and Opinions, from fields including polymer chemistry, biochemistry, physical chemistry, pharmaceutics, medicine, and material science, are welcomed in this Research Topic. Preferred themes of this research topic include but are not limited to: • Lipid-based nanomaterials • Inorganic or organic nanoparticles-based nanomaterials • Polymer-based nanomaterials • Hydrogel-based nanomaterials • Biomimetic nanomaterials • Nanotechnology and biotechnology-based nanomaterials • Stimulus-responsive nanomaterials • Nanomaterials effects and nanotoxicity Keywords: Drug delivery, Nanotechnology, Nanomaterials, Nanozymes, Antibacterial, Polymers, Photothermal Therapy, Noble Metal Nanoparticles. |
» 猜你喜欢
时间戳又变了
已经有6人回复
2026年面上项目中了,2A+B, 会评顺利通过
已经有5人回复
售T0P一区SCI文章,我:8O5.51.O.54,科目齐全,可+急
已经有4人回复
面上项目2026年人工智能评审意见,不知道是否上会
已经有9人回复
售T0P一区SCI文章,我:8O5.51.O.54,科目齐全,可+急
已经有4人回复
大家好,校样时候的紧急求助,请各位帮帮忙了
已经有7人回复
昨日死,今日生
已经有7人回复
售T0P一区SCI文章,我:8O5.51.O.54,科目齐全,可+急
已经有7人回复
植酸TLC薄层色谱爬板
已经有6人回复
单宁酸
已经有3人回复
» 抢金币啦!回帖就可以得到:
南京大学高亚飞课题组招聘金属有机化学2027级博士研究生及研究助理(可转组内博士)
+1/78
工材学部会评时间知道么?
+1/72
中国科学院上海应用物理研究所物性研究组招聘
+2/72
《穿越持科研神辅,杀懵外星万舰》第一章 洞中醒来是异人
+1/41
浙江大学衢州研究院肖成梁课题组招聘博士后及科研助理
+1/36
三氮唑银 问题请教
+1/34
中山大学-中法核工程与技术学院-辐射探测与核电子学课题组招收博士生
+1/30
南科大活性流体和软物质课题组诚招2027级博士、硕士研究生和博后
+1/28
耳石症,好好晕,好难受,有没有同道中人,支个招
+1/26
浙江师范大学膜分离技术团队申利国教授招聘博士后研究人员
+1/24
澳大利亚科廷大学(Curtin University)招收全奖博士生3名
+1/14
香港中文大学(深圳)靳羽华教授招募2027年全奖博士生-材料或有机化学
+2/12
长飞实习生
+1/6
《教育学》
+1/4
上海交通大学化学化工学院张智涛课题组诚聘博士后
+1/4
香港岭南大学博士生和Research Talent Hub(创新及科技基金研究人才库)招聘
+1/1
香港Research Talent Hub(创新及科技基金研究人才库)RA和博士生招聘
+1/1
西南大学·食品学院 招收博士后(多糖/蛋白方向)
+2/1
《财经管理》
+1/1
华南理工大学化学与化工学院博士后招聘启事
+1/1
chenhuanlong
禁虫 (文学泰斗)
★
wlg001(金币+1): 谢谢参与
wlg001(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
7楼2023-05-02 23:29:39
Charles ko
禁虫 (初入文坛)
★
wlg001(金币+1): 谢谢参与
wlg001(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
12楼2023-05-06 15:32:33
简单回复
tzynew2楼
2023-05-02 21:17
回复
wlg001(金币+1): 谢谢参与
o 发自小木虫Android客户端
bjdxyxy3楼
2023-05-02 21:26
回复
wlg001(金币+1): 谢谢参与
。 发自小木虫Android客户端
XG-WUST4楼
2023-05-02 21:55
回复
wlg001(金币+1): 谢谢参与
up 发自小木虫IOS客户端
yuekong5楼
2023-05-02 22:18
回复
nono20096楼
2023-05-02 22:56
回复
wlg001(金币+1): 谢谢参与
·
jiaoxg8楼
2023-05-03 14:46
回复
wlg001(金币+1): 谢谢参与





2023-05-04 09:08
回复
wlg001(金币+1): 谢谢参与
预言的漩涡10楼
2023-05-04 10:55
回复
gter_wang11楼
2023-05-04 13:25
回复
wlg001(金币+1): 谢谢参与











回复此楼